In the quest to cure Alzheimer's, the protein known as beta-amyloid has long taken center stage, driving development of a ...

Imagine diagnosing one of the most challenging neurological diseases with just a quick finger-prick, a few drops of blood and ...

A biomarker test identified tau pathology in Alzheimer's disease before fibrillary tangles developed. Neurofibrillary tangle formation can be prevented by targeting intermediate soluble tau assemblies ...

This news may put some minds at ease. Alzheimer’s disease — which affects an estimated 7 million Americans — is notoriously ...

Years before tau tangles show up in brain scans of patients with Alzheimer's disease, a biomarker test developed at the University of Pittsburgh School of Medicine can detect small amounts of the ...

With two new treatments for Alzheimer’s disease approved in recent years, there’s growing hope for people at risk of the memory-robbing condition. But tests to detect the condition still lag behind.

Researchers at the University of Texas Medical Branch recently discovered a significant advancement in the fight against ...

Besides memory loss, many people with AD also lose their sensitivity to touch. A new study attributes this to a surprising source: neurofibrillary tangles within the spinal cord. In Nature ...

There are currently a few tests, including blood tests, that can be used to help diagnose Alzheimer’s and determine which stage the disease is in. Researchers at WashU Medicine have developed a blood ...

Some people carry Alzheimer’s-related brain damage for years without symptoms. Scientists say the difference lies in brain ...